Posters ECNP Workshop 2014

P.1 Molecular neuropsychopharmacology 

P.1.001 Genes involved in neuroplasticity and short-term response to antidepressant drugs: a complex interplay between genetics and environment
Roberta Emiliani, Italy

P.1.003 Altered surface dynamics of mGlu5 receptor in a mouse model of Fragile X Syndrome
Elisabetta Aloisi, Italy

P.1.005 The trace amine-associated receptor 1 inhibits a hyperglutamatergic state induced by dopamine deficiency
Alexandra Alvarsson, Sweden

P.1.006 Molecular basis of alcohol intake:role of D3 dopaminergic receptor
Chiara B. M. Platania, Italy

P.1.008 Stress rapidly reorganizes the glutamate synapse in the prefrontal cortex of cocaine-withdrawn adolescent rats
Giuseppe Giannotti, Italy

P.1.011 Study of age-dependent effects of ethanol on glutamate dynamics in prefrontal cortex of awake rats using microelectrode amperometry
Devesh Mishra, Sweden

P.1.024 Epigenetic regulation of A2A gene transcription in a model of binge eating in the amygdala complex of female rats
Maria Vittoria Micioni Di Bonaventura, Italy

P.1.030 Three week bright-light intervention has dose-related effects on threat-related corticolimbic reactivity and functional coupling
Patrick Fisher, Denmark

P.2 Behavioural pharmacology

P.2.002 Opposing effects of subtype-specific CRF receptor activation in the adBNST on maternal care and the stress axis in lactating rats
Stefanie Klampfl, Germany

P.2.003 ATP as a regulator of anxiety-like behaviour in the paraventricular nucleus of rats
Stefanie Martinetz, Germany

P.2.005 Fear extinction is modulated by pharmacological enhancers of the endocannabinoid tone depending on the neural subpopulation involved
Álvaro Llorente-Berzal, Spain

P.2.006 The medial septal glutamatergic receptor system involvement in modulation of learning is more pronounced in high responders to novelty
Magdalena Podlacha, Poland

P.2.010 Methamphetamine exposure during pregnancy at pharmacological doses produces neurodevelopmental effects in rat offspring
Kate McDonnell Dowling, Ireland

P.2.012 The effect of the antipsychotic drug remoxipride on memory; a preclinical study utilizing the novel object recognition task
Carolina Bengtsson Gonzales, Sweden

P.2.014 Study the effects of aripiprazole and olanzapine on learning and memory in naïve rats and rats with apomorphine induced behaviour
Mariyan Topolov, Bulgaria

P.2.016 Mouse overexpressing OTX2 shows increased fluctuation in manic- and depressive-like behaviour
Marin Jukic, Israel

P.2.019 The role of ras guanine nucleotide-releasing factor 1 in cocaine self-administration
 Anastasia Olevska, Germany

P.2.025 A novel KV3 ion channel modulator restores cognitive function in an animal model of cognitive impairment in schizophrenia
Marianne Leger, United Kingdom

P.2.027 Modeling EEG endophenotypes in a murine NMDA receptor antagonist model of schizophrenia
Laia Lladó-Pelfort, Spain

P.3 Clinical neuropsychopharmacology

P.3.001 Neurobiological and temperamental assessment in the offspring of bipolar patients with different degrees of lithium response
Ewa Ferensztajn, Poland

P.3.003 Social interaction in cocaine users: altered response to joint attention and underlying functional changes of the reward system
Katrin Preller, Switzerland

P.3.005 BDNF Val66Met polymorphism predicts differential response to antidepressants in depressed Caucasian patients
Romain Colle, France

P.3.007 Comparison between high and low frequency repetitive TMS in the acute treatment of drug-resistant major depression
Giulia Camuri, Italy

P.3.008 Endogenous opioid release in pathological gamblers after an oral amphetamine challenge: a [11C]carfentanil PET study
Inge Mick, United Kingdom

P.3.009 Stabilization of remission from opioid dependence with long-acting naltrexone implant
Sesilia Msekela, Russia

P.3.011 Suicidal ideation in primary care patients: prevalence and psychiatric correlates
Vilma Liaugaudaite, Lithuania

P.3.012 Predictors of second-generation antipsychotic–induced weight gain: a longitudinal study on antipsychotic-naïve patients
Marta Bravo Sanchez, Spain

P.3.013 Genetic Variants in ST8SIA2 gene influence treatment outcome in treatment resistant depression: a European multicenter study
Alexander Kautzky, Austria

P.3.015 Socio-demographic and clinical predictors of antidepressant remission and response in treatment resistant depression
Martina Balestri, Italy

P.3.017 Factors characterizing access and latency to first pharmacological treatment in patients with schizophrenia, mood and anxiety disorders
Neva Suardi, Italy

P.3.018 Insomnia and somnolence induced by second-generation antidepressants during the treatment of major depression: a meta-analysis
Siegfried Alberti, Italy

P.3.020 Comparative efficacy of naltrexone and acamprosate in dual diagnosed schizophrenia and alcohol-dependent patients
Elena-Roxana Bratu, Romania

P.3.021 The effects of duloxetine on subjective, autonomic and neurocognitive response to 7.5% carbon dioxide challenge
Verity Pinkney, United Kingdom

P.3.022 Obstructive sleep apnea, anxiety and depression symptoms in men with coronary artery disease
Alicja Juskiene, Lithuania

P.3.026 The impact of antipsychotic drugs in depression: a role for adult neurogenesis?
Mónica Morais, Portugal

P.3.030 Altered neural activation by emotion regulation and reduced startle response in healthy volunteers after subchronic diazepam treatment
Julia Gottwald, United Kingdom

P.4 Neural and cellular networks in the brain, function and dysfunction

P.4.006 Disrupted effective connectivity of emotional circuitry in schizophrenia: a dynamic causal modeling study
Benedetta Vai, Italy

P.4.013 Fronto-limbic disconnection in bipolar disorder
Giovanna Sferrazza Papa, Italy